Implication of Rho-associated kinase in the elevation of extracellular dopamine levels and its related behaviors induced by methamphetamine in rats

Journal of Neurochemistry

Volumn 86, Issue 2, 2003, Pages 273-282

  Narita, Minoru ^a   Takagi, Misa ^a   Aoki, Kazue ^a   Kuzumaki, Naoko ^a   Suzuki, Tsutomu ^a  

^a HOSHI UNIVERSITY   (Japan)

Author keywords

Dopamine; In vivo microdialysis; Methamphetamine; Morphine; Nucleus accumbens; Rho associated kinase (ROCK)

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; 4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; DOPAMINE; HOMOVANILLIC ACID; METHAMPHETAMINE; MORPHINE; MU OPIATE RECEPTOR AGONIST; RHO KINASE; SODIUM CHANNEL; SODIUM CHANNEL BLOCKING AGENT; TETRODOTOXIN; VANOXERINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DRUG EFFECT; EXTRACELLULAR SPACE; INJECTION; MALE; METABOLITE; MICROINJECTION; NONHUMAN; NUCLEUS ACCUMBENS; PERFUSION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; REARING; SNIFFING;

3,4-DIHYDROXYPHENYLACETIC ACID; AMIDES; ANIMALS; BEHAVIOR, ANIMAL; CENTRAL NERVOUS SYSTEM STIMULANTS; DOPAMINE; DOPAMINE UPTAKE INHIBITORS; DRUG ADMINISTRATION ROUTES; ENZYME INHIBITORS; EXTRACELLULAR SPACE; HOMOVANILLIC ACID; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; METHAMPHETAMINE; MICRODIALYSIS; MORPHINE; NARCOTICS; NUCLEUS ACCUMBENS; PROTEIN-SERINE-THREONINE KINASES; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; TETRODOTOXIN;

ANIMALIA;

EID: 0037479868     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2003.01784.x     Document Type: Article

References (48)

1. Amano M., Ito M., Kimura K., Fukuta Y., Chihara K., Nakano T., Matsuura Y. and Kaibuchi K. (1996) Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase). J. Biol. Chem. 271, 20246-20249.
2. Bito H., Furuyashiki T, Ishihara H., Shibasaki Y., Ohashi K., Mizuno K., Maekawa M., Ishizaki T. and Narumiya S. (2000) A critical role for a Rho-associated kinase, p160ROCK, in determining axon outgrowth in mammalian CNS neurons. Neuron 26, 431-441.
3. Cador M., Rivet J.-M., Kelly A. E., Le Moal M. and Stinus L. (1989) Substance P, neurotensin and enkephalin injections into the ventral tegmental area: comparative study on dopamine turnover in several forebrain structures. Brain Res. 486, 357-363.
4. Camp D. M., Browman K. E. and Robinson T. E. (1994) The effects of methamphetamine and cocaine on motor behavior and extracellular dopamine in the ventral striatum of Lewis versus Fisher 344 rats. Brain Res. 668, 180-193.
5. Caron E. and Hall A. (1998) Identification of two distinct mechanisms of phagocytosis controlled by different Rho GTPases. Science 282, 1717-1721.
6. Davies P. S., Reddy H., Caivano M. and Cohen P. (2000) Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J. 351, 95-105.
7. Di Chiara G. and Imperato A. (1988a) Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Natl Acad. Sci. USA 85, 5274-5278.
8. Di Chiara G. and Imperato A. (1988b) Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats. J. Pharmacol. Exp. Ther. 244, 1067-1080.
9. Domesick V. B., Stinus L. and Paskevich P. A. (1983) The cytology of dopaminergic and nondopaminergic neurons in the substantia nigra and ventral tegmental area of the rat: a light- and electron-microscopic study. Neuroscience 8, 743-765.
10. Dwoskin L. P. and Crooks P. A. (2002) A novel mechanism of action and potential use for lobeline as a treatment for psychostimulant abuse. Biochem. Pharmacol. 63, 89-98.
11. Fischer J. F. and Cho A. K. (1979) Chemical release of dopamine from striatal homogenates: evidence for an exchange diffusion model. J. Parmacol. Exp. Ther 208, 203-209.
12. Fleckenstein A. E., Gibb J. W. and Hanson G. R. (2000) Differential effects of stimulants on monoaminergic transporters: Pharmacological consequences and implications for neurotoxicity. Eur. J. Pharmacol. 406, 1-13.
13. Garzon M. and Pickel V. M. (2001) Plasmalemmal μ-opioid receptor distribution mainly in nondopaminergic neurons in the rat ventral tegmental area. Synapse 41, 311-328.
14. Hackam D. J., Rotstein O. D., Schreiber A., Zhang W.-J. and Grinstein S. (1997) Rho is required for the initiation of calcium signaling and phagocytosis by Fcgamma receptors in macrophages. J. Exp. Med. 186, 955-966.
15. Hall A. (1998) Rho GTPases and the actin cytoskeleton. Science 279, 509-514.
16. Johnson S. W. and North R. A. (1992) Opioids excite dopamine neurons by hyperpolarization of local intemeurons. J. Neurosci. 12, 483-488.
17. Jones S. R., Gaindetdinov R. R., Wightman R. M. and Caron M. G. (1998) Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter. J. Neurosci. 18, 1979-1986.
18. Kaibuchi K., Kuroda S. and Amano M. (1999) Regulation of the cytoskeleton and cell adhesion by the Rho family GTPases in mammalian cells. Annu. Rev. Biochem. 68, 459-486.
19. Kalivas P. W., Wilderlov E., Stanley D., Brees G. and Prange A. J. (1983) Enkephalin action on the mesolimbic dopamine system: a dopamine-dependent and a dopamine-independent increase in locomotor activity. J. Pharmacol. Exp. Ther 227, 229-237.
20. Kimura K., Ito M., Amano M., Chihara K., Fukuta Y., Nakafuku M., Yamamori B., Feng J., Nakano T., Okawa K., Iwamatsu A. and Kaibuchi K. (1996) Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase). Science 273, 245-248.
21. 2+-independent exocytosis from PC 12 cells. Genes Cells 1, 943-951.
22. Koob G. F. (1992) Drug of abuse: anatomy, pharmacology and function of reward pathways. Trends Pharmacol. Sci. 13, 177-184.
23. Koob G. R. and Bloom F. E. (1988) Cellular and molecular mechanisms of drug dependence. Science 242, 715-723.
24. Kowluru A., Li G., Rabaglia M. E., Segu V. B., Hofmann F., Aktories K. and Metz S. A. (1997) Evidence for differential roles of the Rho subfamily of GTP-binding proteins in glucose- and calcium-induced insulin secretion from pancreatic β cells. Biochem. Pharmacol. 54, 1097-1108.
25. Kozma R., Sarner S., Ahmed S. and Lim L. (1997) Rho family GTPases and neuronal growth cone remodeling. Relationship between increased complexity induced by Cdc42Hs, Rac1, and acetylcholine and collapse induced by RhoA and lysophosphatidic acid. Mol. Cell Biol. 17, 1201-1211.
26. Lamaze C., Chuamg T.-H., Terlecky L. J., Bokoch G. M. and Schmid S. L. (1996) Regulation of receptor-mediated endocytosis by Rho and Rac. Nature 382, 177-179.
27. Machesky L. M. and Hall A. (1996) Rho: a connection between membrane receptor signaling and the cytoskeleton. Trends Cell Biol. 6, 304-310.
28. Narita M., Suzuki T., Funada M., Misawa M. and Nagase H. (1993) Blockade of the morphine-induced increase in turnover of dopamine on the mesolimbic dopaminergic system by κ-opioid receptor activation in mice. Life Sci. 52, 397-404.
29. Narita M., Funada M. and Suzuki T. (2001) Regulations of opioid dependence by opioid receptor types. Pharmacol. Ther. 89, 1-15.
30. Narumiya S. (1996) The small GTPase Rho: cellular functions and signal transduction. J. Biochem. 120, 215-228.
31. Norman J. C., Price L. S., Ridley A. J. and Koffer A. (1996) The small GTP-binding proteins, Rac and Rho, regulate cytoskeleton organization and exocytosis in mast cells by parallel pathways. Mol. Biol. Cell 7, 1429-1442.
32. Paxinos G. and Watson C. (1998) The rat brain in stereotaxic coordinates. Academic Press, New York.
33. Pifl C., Drobny H., Reither H., Hornykiewicz O. and Singer E. A. (1995) Mechanism of the dopamine-releasing actions of amphetamine and cocaine: plasmalemmal dopamine transporter versus vesicular monoamine transporter. Mol. Pharmacol. 47, 368-373.
34. Raiteri M., Cerrito F., Cervoni A. M. and Levi G. (1979) Dopamine can be released by two mechanisms differentially affected by the dopamine transport inhibitor nomifensine. J. Pharmacol. Exp. Ther. 208, 195-202.
35. Schmalzing G., Richter H.-P., Hansen A., Schwarz W., Just I. and Aktories K. (1995) Involvement of the GTP binding protein Rho in constitutive endocytosis in Xenopus laevis oocytes. J. Cell Biol. 130, 1319-1332.
36. Seiden L. S., Sabol K. E. and Ricaurte G. A. (1993) Amphetamine: effects on catecholamine systems and behavior. Annu. Rev. Pharmacol. Toxicol. 33, 639-677.
37. Self D. W. and Nestler E. J. (1995) Molecular mechanisms of drug reinforcement and addiction. Annu. Rev. Neurosci. 18, 463-495.
38. Spanagel R. and Weiss F. (1999) The dopamine hypothesis of reward: past and current status. Trends Neurosci. 22, 521-527.
39. Sulzer D., Maidment N. T. and Rayport S. (1993) Amphetamine and other weak bases act to promote reverse transport of dopamine in ventral midbrain neurons. J. Neurochem. 60, 527-535.
40. Sulzer D., Chen T. K., Lau Y. Y., Kristensen H., Rayport S. and Ewing A. (1995) Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport. J. Neurosci. 15, 4102-4108.
41. Tapon N. and Hall A. (1997) Rho, Rac and Cdc42 GTPases regulate the organization of the actin cytoskeleton. Curr. Opin. Cell Biol. 9, 86-92.
42. Ukai M., Toyoshi T. and Kameyama T. (1992) Multidimensional behavioral analyses show dynorphin A-(1-13) modulation of methamphetamne-induced behaviors in mice. Eur. J. Pharmacol. 222, 7-12.
43. Wang H., Moriwaki A., Wang J. B., Uhl G. R. and Pickel V. M. (1997) Ultrastructural immunocytochemical localization of μ-opioid receptors in dendritic targets of dopaminergic terminals in the rat caudate-putamen nucleus. Neurosience 81, 757-771.
44. White F. J. (1996) Synaptic regulation of mesocorticolimbic dopamine neurons. Annu. Rev. Neurosci. 19, 405-436.
45. Wise R. A. (1996) Addictive drugs and brain stimulation reward. Annu. Rev. Neurosci. 19, 319-340.
46. Wise R. A. and Bozarth M. A. (1987) A psychomotor stimulant theory of addiction. Psychol. Rev. 94, 469-492.
47. 2+-dependent exocytosis through Rho/Rho-associated kinase-dependent pathway. J. Neurochem. 75, 708-717.
48. Zhang Y., Loonam T. M., Noailles P. A. and Angulo J. A. (2001) Comparison of cocaine- and methamphetamine-evoked dopamine and glutamate overflow in somatodendritic and terminal field regions of the rat brain during acute, chronic, and early withdrawal conditions. Ann. NY Acad. Sci. 973, 93-120.